| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.24 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |